Related Experiment Video
Updated: May 30, 2026
05:39
Non-Intubated Video-Assisted Thoracoscopic Surgery
Published on: May 26, 2023
Opioids, ventilation and acute pain management.
P E Macintyre1, J A Loadsman, D A Scott
1Acute Pain Service, Department of Anaesthesia, Pain Medicine and Hyperbaric Medicine, Royal Adelaide Hospital and Discipline of Acute Care Medicine, University of Adelaide, Adelaide, South Australia. pamela.macintyre@adelaide.edu.au
Anaesthesia and Intensive Care
|August 10, 2011
Summary
Opioid-induced ventilatory impairment (OIVI) is a critical risk during acute pain management, encompassing respiratory depression, sedation, and airway obstruction. Early detection through monitoring, including sedation scores, is vital to prevent adverse events and ensure patient safety.
Area of Science:
- Anesthesiology
- Pharmacology
- Critical Care Medicine
Background:
- Opioids are primary analgesics for moderate to severe acute pain.
- Concerns exist regarding opioid adverse effects on ventilation.
- Current terminology like 'respiratory depression' is incomplete.
Purpose of the Study:
- Define and elaborate on Opioid-Induced Ventilatory Impairment (OIVI).
- Highlight risks associated with OIVI in acute pain management.
- Advocate for improved monitoring strategies.
Main Methods:
- Review of existing literature on opioid effects on ventilation.
- Analysis of terminology used in studies on sleep-related breathing disorders and opioids.
- Discussion of clinical implications for acute pain management.
Main Results:
- Opioid-Induced Ventilatory Impairment (OIVI) is a comprehensive term including central respiratory depression, sedation, and upper airway obstruction.
- OIVI can lead to decreased alveolar ventilation and increased arterial carbon dioxide.
- Misuse of terminology regarding sleep apnea and hypoventilation complicates OIVI discussions.
- Focusing solely on pain scores without OIVI monitoring increases adverse events.
Conclusions:
- Appropriate monitoring for OIVI is essential in patients receiving opioids for acute pain.
- Sedation scores should be considered a '6th vital sign' for early OIVI detection.
- Timely intervention based on OIVI monitoring can mitigate risks and improve patient outcomes.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:20Inhalational Anesthetics: Overview
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...